These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23127309)

  • 21. SNPs and breast cancer risk prediction for African American and Hispanic women.
    Allman R; Dite GS; Hopper JL; Gordon O; Starlard-Davenport A; Chlebowski R; Kooperberg C
    Breast Cancer Res Treat; 2015 Dec; 154(3):583-9. PubMed ID: 26589314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
    Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
    Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing absolute changes in breast cancer risk due to modifiable risk factors.
    Quante AS; Herz J; Whittemore AS; Fischer C; Strauch K; Terry MB
    Breast Cancer Res Treat; 2015 Jul; 152(1):193-197. PubMed ID: 26012643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
    Amir E; Evans DG; Shenton A; Lalloo F; Moran A; Boggis C; Wilson M; Howell A
    J Med Genet; 2003 Nov; 40(11):807-14. PubMed ID: 14627668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.
    Dite GS; Mahmoodi M; Bickerstaffe A; Hammet F; Macinnis RJ; Tsimiklis H; Dowty JG; Apicella C; Phillips KA; Giles GG; Southey MC; Hopper JL
    Breast Cancer Res Treat; 2013 Jun; 139(3):887-96. PubMed ID: 23774992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study.
    Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1187-1194. PubMed ID: 31015199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
    Banegas MP; John EM; Slattery ML; Gomez SL; Yu M; LaCroix AZ; Pee D; Chlebowski RT; Hines LM; Thompson CA; Gail MH
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28003316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.
    Gail MH
    J Natl Cancer Inst; 2009 Jul; 101(13):959-63. PubMed ID: 19535781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining Breast Cancer Risk Prediction Models.
    Guan Z; Huang T; McCarthy AM; Hughes K; Semine A; Uno H; Trippa L; Parmigiani G; Braun D
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
    Jacobi CE; de Bock GH; Siegerink B; van Asperen CJ
    Breast Cancer Res Treat; 2009 May; 115(2):381-90. PubMed ID: 18516672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting breast cancer risk using personal health data and machine learning models.
    Stark GF; Hart GR; Nartowt BJ; Deng J
    PLoS One; 2019; 14(12):e0226765. PubMed ID: 31881042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
    Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
    J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.
    McCarthy AM; Armstrong K; Handorf E; Boghossian L; Jones M; Chen J; Demeter MB; McGuire E; Conant EF; Domchek SM
    Breast Cancer Res Treat; 2013 Apr; 138(3):889-98. PubMed ID: 23474973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
    Pal Choudhury P; Wilcox AN; Brook MN; Zhang Y; Ahearn T; Orr N; Coulson P; Schoemaker MJ; Jones ME; Gail MH; Swerdlow AJ; Chatterjee N; Garcia-Closas M
    J Natl Cancer Inst; 2020 Mar; 112(3):278-285. PubMed ID: 31165158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening.
    Lehman CD; Mercaldo S; Lamb LR; King TA; Ellisen LW; Specht M; Tamimi RM
    J Natl Cancer Inst; 2022 Oct; 114(10):1355-1363. PubMed ID: 35876790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.